SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16166794
Source:
http://linkedlifedata.com/resource/pubmed/id/16166794
Search
Subject
(
63
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0021747
,
umls-concept:C0023981
,
umls-concept:C0030705
,
umls-concept:C0205099
,
umls-concept:C0205171
,
umls-concept:C0524910
,
umls-concept:C1516463
pubmed:issue
1-2
pubmed:dateCreated
2005-9-16
pubmed:abstractText
The anticarcinogenic capacity of interferon (IFN) was assessed in a cohort of Japanese patients with chronic hepatitis C en masse.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0364265
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status
MEDLINE
pubmed:issn
0300-5526
pubmed:author
pubmed-author:AkutaNorioN
,
pubmed-author:AraseYasujiY
,
pubmed-author:HosakaTetsuyaT
,
pubmed-author:IkedaKenjiK
,
pubmed-author:KobayashiMasahiroM
,
pubmed-author:KumadaHiromitsuH
,
pubmed-author:SaitohSatoshiS
,
pubmed-author:SezakiHitomiH
,
pubmed-author:SomeyaTakashiT
,
pubmed-author:SuzukiFumitakaF
,
pubmed-author:SuzukiYoshiyukiY
pubmed:copyrightInfo
Copyright (c) 2006 S. Karger AG, Basel.
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
82-90
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16166794-Adolescent
,
pubmed-meshheading:16166794-Adult
,
pubmed-meshheading:16166794-Aged
,
pubmed-meshheading:16166794-Antiviral Agents
,
pubmed-meshheading:16166794-Carcinoma, Hepatocellular
,
pubmed-meshheading:16166794-Cohort Studies
,
pubmed-meshheading:16166794-Female
,
pubmed-meshheading:16166794-Hepatitis C, Chronic
,
pubmed-meshheading:16166794-Humans
,
pubmed-meshheading:16166794-Interferon Type I
,
pubmed-meshheading:16166794-Interferon-beta
,
pubmed-meshheading:16166794-Japan
,
pubmed-meshheading:16166794-Liver Neoplasms
,
pubmed-meshheading:16166794-Male
,
pubmed-meshheading:16166794-Middle Aged
,
pubmed-meshheading:16166794-Multivariate Analysis
,
pubmed-meshheading:16166794-Recombinant Proteins
,
pubmed-meshheading:16166794-Retrospective Studies
,
pubmed-meshheading:16166794-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.
pubmed:affiliation
Department of Gastroenterology, Toranomon Hospital, Toranomon 2-2-2, Minato-ku, Tokyo 105-8470, Japan. ikedakenji@tora.email.ne.jp
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't